Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-13

Clinical Trial Update: Tripeptide/Hexapeptide Topical and Hybrid Laser Treatment for Acne Scarring [NA]

View source ↗

Summary

A completed clinical trial evaluating a topical tripeptide/hexapeptide treatment combined with a hybrid laser for acne scars (mixed atrophic and hypertrophic). …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hybrid laser treatment
  • Tripeptide/Hexapeptide topical agent (investigational)

Snippet

Sponsor: University of Rochester | Conditions: Acne Scars - Mixed Atrophic and Hypertrophic | NA | Status: COMPLETED | Results posted: 2023-04-13